Document Detail


Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin.
MedLine Citation:
PMID:  3331045     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Imipenem/cilastatin at a dose of 0.5 g six hourly was compared to conventional combination therapy with ampicillin 0.5 g six hourly, metronidazole 0.5 g eight hourly and gentamicin 80 mg eight hourly (with dose adjustment by trough and peak serum levels) in the treatment of severe intra-abdominal infections. All antibiotics were given intravenously. Forty-five patients entered the trial. Of the 19 evaluable patients in the imipenem/cilastatin group, 16 were clinically cured with five microbiological successes and two failures. Of 24 evaluable patients in the combination group, 22 were clinically cured with one microbiological success and one failure. One patient in each group suffered an adverse effect. Patients in the I/C group tended to be older with more women and more severe infections. The origin of peritonitis was similar. I/C did not differ from combination therapy in efficacy or safety and was comparable in cost. However, I/C was easier to administer than combination therapy and there was no need for serum concentration monitoring.
Authors:
D J Leaper; R H Kennedy; A Sutton; E Johnson; N Roberts
Related Documents :
7001295 - The prophylactic use of metronidazole in caesarean section.
17855185 - Metronidazole single versus multiple daily dosing in serious intraabdominal/pelvic and ...
6357175 - The prevention of postappendicectomy sepsis by metronidazole and cotrimoxazole: a contr...
20922415 - Clinical efficacy of saccharomyces boulardii or metronidazole in symptomatic children w...
23732265 - Outpatient versus hospitalization management for uncomplicated diverticulitis: a prospe...
6824285 - Comparison of subjective and radiological findings during the course of acute maxillary...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Scandinavian journal of infectious diseases. Supplementum     Volume:  52     ISSN:  0300-8878     ISO Abbreviation:  Scand J Infect Dis Suppl     Publication Date:  1987  
Date Detail:
Created Date:  1988-08-18     Completed Date:  1988-08-18     Revised Date:  2009-10-28    
Medline Journal Info:
Nlm Unique ID:  0251025     Medline TA:  Scand J Infect Dis Suppl     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  7-10     Citation Subset:  IM    
Affiliation:
University Department of Surgery, Southmead Hospital, Bristol, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Ampicillin / administration & dosage
Anti-Bacterial Agents / therapeutic use*
Bacterial Infections / drug therapy*
Cilastatin
Clinical Trials as Topic
Cyclopropanes / administration & dosage
Drug Combinations / administration & dosage
Drug Therapy, Combination
Female
Gentamicins / administration & dosage
Humans
Imipenem
Male
Metronidazole / administration & dosage
Middle Aged
Peritonitis / drug therapy*,  etiology
Random Allocation
Thienamycins / administration & dosage
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Cyclopropanes; 0/Drug Combinations; 0/Gentamicins; 0/Thienamycins; 443-48-1/Metronidazole; 69-53-4/Ampicillin; 74431-23-5/Imipenem; 82009-34-5/Cilastatin; 92309-29-0/cilastatin, imipenem drug combination

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic ...
Next Document:  Induction of ovulation with pulsatile LHRH.